Dr. Henry Kranzler, MD
Claim this profileUniversity of Pennsylvania Center for Studies of Addiction
Studies Alcohol Consumption
Studies Alcoholism
8 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Henry Kranzler, MD is currently running
Ketogenic Diet
for Alcohol Metabolism
The research study is being conducted in health controls to better understand the effects of ketosis on brain functioning after 3 different, randomly assigned, 3-day dietary interventions and the acute effects of alcohol after consuming about 4-5 alcohol beverages. The labs visits will use magnetic resonance imaging (MRI) scans to study the brain, measuring levels of nicotinamide adenine dinucleotide (NAD), lactate, neurotransmitters glutamate, and Gamma-aminobutyric acid (GABA).
Recruiting0 awards Phase 2 & 32 criteria
Ibudilast
for Alcohol Use Disorder
This is a research study involving 6 weeks of study medication, Ibudilast or a placebo (an inactive substance) and medical management counseling to reduce or stop drinking. Ibudilast is not approved by the U.S. FDA for clinical use in the United States, but it is has been used for many years in Japan for its anti-inflammatory effects. Its use in the treatment of alcohol dependence is experimental. By reducing inflammation, Ibudilast may help some people reduce or stop drinking. We have obtained an Investigational New Drug Application (IND) approval for this study from the FDA. Ibudilast has been used clinically for 20 years in Asia for treating bronchial asthma and, more recently, for post-stroke dizziness and ocular allergies and has been shown to be safe and well tolerated.
Recruiting0 awards Phase 28 criteria
More about Henry Kranzler, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Henry Kranzler, MD has experience with
- Ketone Supplement
- Medical Management
- Placebo Intramuscular Injection
- XR-NTX 380 Mg, Intramuscular Injection
- Ibudilast
- Empower Neuromodulation System
Breakdown of trials Henry Kranzler, MD has run
Alcohol Consumption
Alcoholism
Alcohol Use Disorder
Alcohol Withdrawal Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Henry Kranzler, MD specialize in?
Henry Kranzler, MD focuses on Alcohol Consumption and Alcoholism. In particular, much of their work with Alcohol Consumption has involved treating patients, or patients who are undergoing treatment.
Is Henry Kranzler, MD currently recruiting for clinical trials?
Yes, Henry Kranzler, MD is currently recruiting for 4 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Henry Kranzler, MD has studied deeply?
Yes, Henry Kranzler, MD has studied treatments such as Ketone Supplement, Medical Management, Placebo intramuscular injection.
What is the best way to schedule an appointment with Henry Kranzler, MD?
Apply for one of the trials that Henry Kranzler, MD is conducting.
What is the office address of Henry Kranzler, MD?
The office of Henry Kranzler, MD is located at: University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania Center for Studies of Addiction.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.